H4628
DL-Homocysteine
≥95% (titration)
Synonym(s):
2-Amino-4-mercaptobutyric acid
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
HSCH2CH2CH(NH2)COOH
CAS Number:
Molecular Weight:
135.18
NACRES:
NA.26
PubChem Substance ID:
eCl@ss:
42021308
UNSPSC Code:
12352209
EC Number:
207-222-9
MDL number:
Beilstein/REAXYS Number:
1721683
Product Name
DL-Homocysteine, ≥95% (titration)
Quality Level
assay
≥95% (titration)
form
powder
mp
232-233 °C (lit.)
solubility
H2O: soluble
application(s)
cell analysis
peptide synthesis
storage temp.
−20°C
SMILES string
NC(CCS)C(O)=O
InChI
1S/C4H9NO2S/c5-3(1-2-8)4(6)7/h3,8H,1-2,5H2,(H,6,7)
InChI key
FFFHZYDWPBMWHY-UHFFFAOYSA-N
Application
DL-Homocysteine has been used to induce hyperhomocysteinemia in Sprague–Dawley rats. It has also been used to study the effects of hyperhomocysteinemia on atherosclerosis in apolipoprotein E-deficient mice.
Biochem/physiol Actions
Homocysteine is a sulfhydryl-containing amino acid, synthesized from methionine. It is a non-essential, non-proteinogenic amino acid. It is an important determinant of the methylation cycle and is present in the plasma in four forms. An abnormally high level of homocysteine leads to hyperhomocysteinemia and also promotes atherosclerosis.
Increased plasma homocysteine is a risk factor for coronary heart disease and carcinogenesis; may be a marker for tumor cell growth.
Still not finding the right product?
Explore all of our products under DL-Homocysteine
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Homocysteine: role and implications in atherosclerosis.
Guthikonda S and Haynes WG
Current Atherosclerosis Reports, 8(2), 100-106 (2006)
Hyperhomocysteinemia decreases bone blood flow
Neetu Tyagi
Vascular Health, 7, 31-35 (2011)
Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice
Ji Zhou
Atherosclerosis, 168(2), 255-262 (2003)